TCL Archive Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage March 21, 2014
TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen November 25, 2005
